银华中证创新药产业ETF发起式联接A(012781)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
43,752,600 |
45,234,900 |
8,654,120 |
7,171,870 |
1,482,250 |
3.39% |
2023/12/31 |
12,429,500 |
43,752,600 |
47,214,800 |
15,891,600 |
31,323,200 |
252.01% |
2023/12/31 |
29,943,800 |
43,752,600 |
25,453,700 |
11,644,900 |
13,808,800 |
46.12% |
2023/9/30 |
17,598,500 |
29,943,800 |
14,762,200 |
2,416,900 |
12,345,300 |
70.15% |
2023/6/30 |
12,429,500 |
17,598,500 |
6,998,790 |
1,829,810 |
5,168,980 |
41.59% |
2023/6/30 |
13,551,700 |
17,598,500 |
5,419,690 |
1,372,900 |
4,046,790 |
29.86% |
2023/3/31 |
12,429,500 |
13,551,700 |
1,579,100 |
456,912 |
1,122,188 |
9.03% |
2022/12/31 |
10,252,600 |
12,429,500 |
3,537,910 |
1,361,070 |
2,176,840 |
21.23% |
2022/12/31 |
11,939,800 |
12,429,500 |
967,651 |
477,956 |
489,695 |
4.1% |
2022/9/30 |
11,317,500 |
11,939,800 |
936,217 |
313,973 |
622,244 |
5.5% |
2022/6/30 |
10,252,600 |
11,317,500 |
1,634,040 |
569,138 |
1,064,902 |
10.39% |
2022/6/30 |
10,775,900 |
11,317,500 |
652,631 |
110,969 |
541,662 |
5.03% |
2022/3/31 |
10,252,600 |
10,775,900 |
981,407 |
458,168 |
523,239 |
5.1% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。